Jump to main content
Jump to site search

Issue 3, 2012
Previous Article Next Article

Antimalarialperoxides: advances in drug discovery and design

Author affiliations

Abstract

Cyclic peroxides such as the plant-derived 1,2,4-trioxane artemisinin and its derivatives are short-lived, rapidly-acting antimalarials that are now usually combined with standard long-lived, alkaloidal antimalarials; such artemisinin combination therapy (ACT) is the worldwide standard operating procedure for malaria chemotherapy. This review discusses antimalarial monomeric and dimeric derivatives of artemisinin, peroxides not derived from artemisinin, and finally hybrids containing one peroxide unit covalently linked to a non-peroxide unit. Emphasis is placed on the antimalarial effectiveness of these diverse cyclic peroxides and on the simplicity of their synthesis.

Graphical abstract: Antimalarial peroxides: advances in drug discovery and design

Back to tab navigation

Article information


Submitted
02 Nov 2011
Accepted
06 Dec 2011
First published
07 Dec 2011

Med. Chem. Commun., 2012,3, 281-297
Article type
Review Article

Antimalarial peroxides: advances in drug discovery and design

R. D. Slack, A. M. Jacobine and G. H. Posner, Med. Chem. Commun., 2012, 3, 281
DOI: 10.1039/C2MD00277A

Search articles by author

Spotlight

Advertisements